Natural Product (NP) Details
General Information of the NP (ID: NP6785) | |||||
---|---|---|---|---|---|
Name |
Brucine
|
||||
Synonyms |
BRUCINE; 357-57-3; 10,11-Dimethoxystrychnine; Brucinum; (-)-Brucine; l-Brucine; 2,3-Dimethoxystrychnine; 2,3-Dimethoxystrychnidin-10-one; 10,11-Dimethystrychnine; UNII-6NG17YCK6H; Brucina; Brucin; 6NG17YCK6H; Brucine alkaloid; CHEBI:3193; Dimethoxy strychnine; Bruzin; 2,3-Dimethoxy-strychnine; RCRA waste number P018; DSSTox_RID_77490; DSSTox_GSID_24662; Strychnine, 2,3-dimethoxy-; 145428-94-0; Brucin [German]; Brucina [Italian]; (4aR,4a1R,5aS,8aR,8a1S,15aS)-10,11-dimethoxy-2,4a,4a1,5,5a,7,8,8a1,15,15a-decahydro-14H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one; CAS-357-57-3; SMR000112281; DSSTox_CID_4662; 10,11-dimethoxy strychnine; CCRIS 4754; HSDB 307; anhydrous brucine; Bisdesmethylbrucin; Brucine Anhydrous; UN 1570; NCGC00094861-01; (4aR,5aS,8aR,13aS,15aS,15bR)-10,11-dimethoxy-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one; EINECS 206-614-7; UN1570; PubChem7945; RCRA waste no. P018; Brucine, anhydrous, 98%; GTPL342; MLS000515808; MLS001424166; SCHEMBL113229; CHEMBL501756; MEGxp0_001865; DTXSID2024662; ACon1_001990; Brucine [UN1570] [Poison]; HMS2052O03; HMS2268L16; ZINC1069090; Tox21_111349; Tox21_302174; BDBM50401037; MFCD00005942; AKOS015955678; AKOS024282466; CCG-101078; MCULE-9524496694; NC00328; NSC 757797; NCGC00255253-01; NCGC00263445-02; NCGC00384497-01; M127; B0670; B0946; C09084; Brucine - CASMI2016 Category 1 - Challenge 9; Q411022; SR-01000712407; Q-100426; SR-01000712407-5; BRD-K68077509-001-01-6; Brucine, European Pharmacopoeia (EP) Reference Standard; (1R,11S,18S,20R,21R,22S)-4,5-dimethoxy-12-oxa-8,17-diazaheptacyclo[15.5.2.0^{1,18}.0^{2,7}.0^{8,22}.0^{11,21}.0^{15,20}]tetracosa-2(7),3,5,14-tetraen-9-one
Click to Show/Hide
|
||||
Species Origin | Strchnos icaja ... | Click to Show/Hide | |||
Strchnos icaja | |||||
Disease | Hepatocellular carcinoma [ICD-11: 2C12] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C23H26N2O4
|
||||
PubChem CID | |||||
Canonical SMILES |
COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC
|
||||
InChI |
1S/C23H26N2O4/c1-27-16-8-14-15(9-17(16)28-2)25-20(26)10-18-21-13-7-19-23(14,22(21)25)4-5-24(19)11-12(13)3-6-29-18/h3,8-9,13,18-19,21-22H,4-7,10-11H2,1-2H3/t13-,18-,19-,21-,22-,23+/m0/s1
|
||||
InChIKey |
RRKTZKIUPZVBMF-IBTVXLQLSA-N
|
||||
CAS Number |
CAS 357-57-3
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Gemcitabine | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | p105 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | ||
Experimental
Result(s) |
Brucine, either individually or in combination, but not gemcitabine, inhibited NF-kB subunit (p65) expression in MCF-7 cells. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Muscarinic acetylcholine receptor M3 (CHRM3) | Molecule Info | [3] | |
KEGG Pathway | Calcium signaling pathway | Click to Show/Hide | ||
2 | Neuroactive ligand-receptor interaction | |||
3 | Cholinergic synapse | |||
4 | Regulation of actin cytoskeleton | |||
5 | Insulin secretion | |||
6 | Salivary secretion | |||
7 | Gastric acid secretion | |||
8 | Pancreatic secretion | |||
Panther Pathway | Alzheimer disease-amyloid secretase pathway | Click to Show/Hide | ||
2 | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||
3 | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Pathwhiz Pathway | Gastric Acid Production | Click to Show/Hide | ||
Reactome | Muscarinic acetylcholine receptors | Click to Show/Hide | ||
2 | Acetylcholine regulates insulin secretion | |||
3 | G alpha (q) signalling events | |||
WikiPathways | Monoamine GPCRs | Click to Show/Hide | ||
2 | Calcium Regulation in the Cardiac Cell | |||
3 | Regulation of Actin Cytoskeleton | |||
4 | GPCRs, Class A Rhodopsin-like | |||
5 | Gastrin-CREB signalling pathway via PKC and MAPK | |||
6 | Integration of energy metabolism | |||
7 | GPCR ligand binding | |||
8 | GPCR downstream signaling | |||
9 | GPCRs, Other |